Fasikl
Bloomington, MNFounded 2019
- Wearables
- Series B
Fasikl is a NeuroAI company spun out of the University of Minnesota that develops AI-based therapies for neurological conditions. Drawing on more than 20 years of neural engineering research, it offers products including the Felix NeuroAI™ Wristband and Fasikl-X™.
- TrialClinical trial
- 1
- RaisedTotal raised
- $59.9M
- Sep 2025Latest priced round, Sep 2025
- Series B
- Investors
- 3
- Founded
- 2019
reccy insights
Fasikl’s most consequential product milestone was FDA clearance for its Felix NeuroAI Wristband, announced on July 1, 2025. The prescription-only wearable uses AI-controlled peripheral nerve stimulation for essential tremor. On October 20, 2025, Fasikl announced that the wristband was available by prescription in select U.S. regions and highlighted findings published in JAMA Neurology describing improved daily function for people with essential tremor. These developments marked a shift from regulatory progress toward initial commercialization and clinical evidence. Fasikl also raised a $26.56 million Series B on September 17, 2025, with Qiming Venture Partners participating as an investor. In August 2026, Twin Cities Business published a company profile, adding a later local business update. The company’s timeline also includes two patent publications in September 2025 concerning electrical stimulation based on physiological parameters and peripheral nerve signal acquisition. Public information provided here does not detail sales, patient uptake, or the commercial reach of the prescription launch, so the scale of adoption remains unclear.
Written by reccy's AI from company sites, press and funding records · updated Oct 2026
What makes Fasikl distinct
- 01Combines artificial intelligence with more than 20 years of neural engineering research.
- 02Develops therapies for neurological conditions, including a noninvasive wearable for essential tremor.
- 03Describes its approach as centered on patient needs, experiences, and quality of life.
- 04Emphasizes science, real-world evidence, and ongoing improvement.
- 05Spun out of the University of Minnesota.
Technology & products2
- Felix NeuroAI™ Wristband
A noninvasive wearable therapeutic for adults with essential tremor that uses AI-controlled peripheral nerve stimulation to reduce tremor-related upper-limb functional limitations.
- MindForce™ Nerve-Computer Interface (NCI) System
An investigational nerve-computer interface that decodes peripheral nerve signals to provide intuitive control of robotic limbs, computers, and other assistive devices, with applications in pain management.
- NeuroAI platform for AI-based therapies targeting neurological conditions.
- Felix NeuroAI™ Wristband, using AI-controlled peripheral nerve stimulation for essential tremor.
- MindForce™ Nerve-Computer Interface System for decoding peripheral nerve signals.
- Fasikl-X™.
Clinical trials1
- Assessment of the Safety and Efficacy of the Felix NeuroAI Wristband in Essential TremorActive, not recruitingNCT06235190 · 126 participants · started Feb 2024
- Essential Tremor
Recent updates5
- Oct 8, 2026Award
Fasikl Co-Founder and CEO Zhi Yang Receives 2026 BMES Wallace H. Coulter Award for Healthcare Innovation
fasikl.com - Dec 31, 2025Product launch
Fasikl announced FDA clearance and a planned launch of the Felix NeuroAI Wristband, with initial availability in select U.S. regions described for 2025.
businesswire.com - Oct 20, 2025Product launch
Fasikl announced that its FDA-cleared Felix NeuroAI Wristband was available by prescription in select U.S. regions, marking initial commercialization of its AI-powered essential tremor therapy.
morningstar.com
In the Cortex
Funding
- Series BSep 2025$26.6M
- Series ASep 2024$18.3MLed by iSeed Ventures, Tailwind Ventures
- Series AMar 2023$10M
Similar companies
About Fasikl
- Products
- Felix NeuroAI™ Wristband, MindForce™ Nerve-Computer Interface (NCI) System
- Leadership
- Zhi Yang, CEO & Co-FounderEdward Keefer, CSO and Co-founder
- Focus areas
- NeuroAI, neural engineering, medical devices, digital health, therapeutics, wearables
- Headquarters
- Bloomington, MN
- Founded
- 2019
- Employees
- 11–50